Knowledge

Our knowledge resources reflect the breadth and depth of our expertise, our insight into the issues which matter to your business, and our understanding of the markets in which you operate.

Knowledge

<p>Filter Knowledge</p>

  • Filter Knowledge

    Articles Filtering:

2750 Results

£167 million IPO for Hotel Chocolat

Travers Smith corporate finance partner Adrian West and corporate finance associate Lucy Stephenson have advised Liberum Capital Limited in its capacity as nominated adviser and broker to Hotel Chocolat Group Plc ("Hotel Chocolat") in connection with its £167 million IPO and £55.5 million placing of new and existing shares.

Muzinich & Co invests in Phaidon International

Travers Smith LLP has advised Muzinich & Co. Limited (“Muzinich”) in relation to the provision of a debt package totalling £18million to Phaidon International (“Phaidon”), a specialist recruiter operating in the US, Europe and Asia.

Zoopla acquires Property Software Group for £75m

Travers Smith LLP has advised existing client Zoopla Property Group Plc, the digital media and lead generation platform that owns and operates some of the UK's leading online consumer brands including Zoopla, uSwitch and PrimeLocation, on the acquisition of Property Software Group (PSG) from LDC and certain management sellers for up to £75m.

Micro Focus to acquire Serena Software for $540 Million

Travers Smith has advised international software and application management solutions group Micro Focus on its proposed acquisition of Serena Software, a leading provider of enterprise software focused on providing Application Lifecycle Management products for both mainframe and distributed systems.

£48.4m Placing by Dechra Pharmaceuticals plc

Travers Smith corporate partner Richard Spedding and senior counsel Dan McNamee have advised Investec, as sole bookrunner, underwriter and financial adviser, on the placing by Dechra Pharmaceuticals plc that was made to part fund the conditional acquisition of the entire share capital of Putney, Inc, a leading developer of generic companion animal pharmaceuticals in the US. 

Back To Top Back To Top chevron up